Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Blood|October 16, 2009
Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cellsYongchao Wang, Warren Fiskus, Daniel G Chong, et al.
Cancer Research|March 7, 2014
Auranofin induces lethal oxidative and endoplasmic reticulum stress and exerts potent preclinical activity against chronic lymphocytic leukemiaWarren Fiskus, Nakhle Saba, Min Shen, et al.
Molecular Cancer Therapeutics|January 18, 2014
Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cellsWarren Fiskus, Sunil Sharma, Jun Qi, et al.
Expert Opinion on Investigational Drugs|August 13, 2009
Investigational drugs targeting FLT3 for leukemiaCelalettin Ustun, David L DeRemer, Anand P Jillella, et al.
DNA and Cell Biology|August 28, 2003
Molecular cloning and analysis of a region of the Bartonella bacilliformis genome encoding NlpD, L-isoaspartyl methyltransferase and YajC homologsIndira Padmalayam, Warren Fiskus, Robert F Massung, et al.
Leukemia|March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
DNA and Cell Biology|December 9, 2003
Identification and characterization of the DdlB, FtsQ and FtsA genes upstream of FtsZ in Bartonella bacilliformis and Bartonella henselaeWarren Fiskus, Indira Padmalayam, Tim Kelly, et al.
Blood Cancer Journal|January 12, 2022
Effective Menin inhibitor-based combinations against AML with MLL rearrangement or NPM1 mutation (NPM1c)Warren Fiskus, Steffen Boettcher, Naval Daver, et al.
Leukemia|December 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AMLChristine E Birdwell, Warren Fiskus, Christopher P Mill, et al.
Blood|October 3, 2021
Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2Christopher P Mill, Warren Fiskus, Courtney D DiNardo, et al.
Pageof 13